NASDAQ
Arch Therapeutics, Inc. (ARTH) has a current ratio of 0.21x as of Monday, May 25, 2026. This represents a 91.98% decrease compared to its 12-month average of 2.57x. The current ratio measures a company's ability to cover short-term obligations by comparing current assets to current liabilities.
No price data available for this timeframe.